Alpha-methyltyrosine reduces the acute cardiovascular and behavioral sequelae in a murine model of traumatic brain injury
- 11 May 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 95 (4) , 542-548
Abstract
BACKGROUND: Increased catecholamines contribute to heightened cardiovascular reactivity and behavioral deficits after traumatic brain injury (TBI); adrenergic receptor blockade has limited success in reducing adverse sequelae of TBI. Injury-induced increases in the synthesis of catecholamines could contribute to adverse outcomes in TBI. Inhibition of catecholamine synthesis with alpha-methyltyrosine (αMT) could offer a benefit after TBI. METHODS: Original research trial in mice randomized to αMT (50 mg·kg−1·d−1) or vehicle for 1 week after TBI induced by controlled cortical impact. Primary outcomes of cardiovascular reactivity and behavioral deficits were assessed after 1 week. Secondary outcomes included blood brain barrier permeability and quantification of gene transcription whose products determine intraneuronal chloride concentrations, the release of catecholamines, and activation of the sympathetic nervous system. These genes were the alpha-2 adrenergic receptor (“Adra2c”), the sodium-potassium-chloride cotransporter (“Nkcc1”), and the potassium chloride cotransporter (“Kcc2”). We also assessed the effect of TBI and αMT on the neuronal chloride/bicarbonate exchanger (“Ae3”). RESULTS: Traumatic brain injury–induced increases in blood pressure and cardiac reactivity were blocked by αMT. Inhibition of catecholamine synthesis decreased blood brain barrier leakage and improved behavioral outcomes after TBI. Traumatic brain injury diminished the transcription of Adra2c and enhanced expression of Nkcc1 while reducing Kcc2 transcription; αMT prevented the induction of the Nkcc1 by TBI without reversing the effects of TBI on Kcc2 expression; αMT also diminished Ae3 transcription. CONCLUSION: Traumatic brain injury acutely increases cardiovascular reactivity and induces behavioral deficits in an αMT-sensitive manner, most likely by inducing Nkcc1 gene transcription. Alpha-methyltyrosine may prove salutary in the treatment of TBI by attenuating the enhanced expression of Nkcc1, minimizing blood brain barrier leakage, and diminishing central catecholamine and sympathetic output. We also found an unreported relationship between Kcc2 and the chloride/bicarbonate exchanger, which should be considered in the design of trials planned to manipulate central intraneuronal chloride concentrations following acute brain injury.Keywords
This publication has 39 references indexed in Scilit:
- The effect of repeated stress on KCC2 and NKCC1 immunoreactivity in the hippocampus of female miceData in Brief, 2016
- Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and SerotoninJournal of Neurotrauma, 2015
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersPharmacology & Therapeutics, 2014
- Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trialTrials, 2012
- NKCC1 Upregulation Disrupts Chloride Homeostasis in the Hypothalamus and Increases Neuronal Activity-Sympathetic Drive in HypertensionJournal of Neuroscience, 2012
- Cardiac Reactive Oxygen Species After Traumatic Brain InjuryJournal of Surgical Research, 2012
- NKCC1 cotransporters: keeping an ‘ion’ themThe Journal of Physiology, 2011
- Alpha-methyltyrosine inhibits formation of reactive oxygen species and diminishes apoptosis in PC12 cellsBrain Research, 2009
- Early Changes in KCC2 Phosphorylation in Response to Neuronal Stress Result in Functional DownregulationJournal of Neuroscience, 2007
- Neurotoxicity of MAO Metabolites of Catecholamine Neurotransmitters: Role in Neurodegenerative DiseasesNeuroToxicology, 2004